NIH-funded research R21 grant

Image-guided, flexible CAR T therapy for solid tumors

Official title: Image-guided adaptable CAR T cell therapy for solid tumors

Funded at Methodist Hospital Research Institute · NIH-11282814 · Data updated 2026-11-12

A new, image-guided CAR T approach uses a universal adaptor to target solid tumors and help predict where therapy goes, aiming to reduce relapse and off-target effects.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionMethodist Hospital Research Institute
NIH-funded
Lab location1 site (Houston, United States)
Project startJune 9, 2026
Project endJuly 31, 2028
Funding year2026
Award (this year)$415,257
NIH project number1R21CA299243-01A1
Project IDNIH-11282814 on NIH RePORTER

Who could benefit from this research

Could help

Adults with B cell malignancies or solid tumors where image-guided adaptor CAR T therapy could be applicable.

Less likely to help

Patients without suitable tumor targets or those unable to undergo CAR T cell therapy may not benefit.

What this research studies

This project develops a universal CAR T system that uses a tumor-targeting adaptor molecule attached to a CAR T cell. It will image adaptor distribution with PET to guide treatment, administer autologous CAR T cells with optimized adaptors, and monitor tumor response and CAR T activity using PET imaging. The goal is to improve targeting of solid tumors and reduce toxicities by predicting where CAR T cells will go and how they behave in the body.

Why it matters

Potential benefit: If successful, patients could benefit from more accurate targeting of CAR T therapy for solid tumors with fewer side effects and better tumor control.

How similar studies have gone: Previous CAR T approaches work well for some blood cancers but struggle with solid tumors; this image-guided adaptor strategy is a novel approach with early supportive evidence.

Where this research is happening

  • Methodist Hospital Research Institute
    Houston, United States
    Active

Researchers

  • Principal investigator: Jin, Moonsoo M. — Methodist Hospital Research Institute
  • Study coordinator: Jin, Moonsoo M.

Related research

Other NIH-funded projects on the same topics.

  • Remote-controlled PC-CAR T cells for hard-to-treat solid tumors

    A new drug-free approach aims to let immune cells recognize and fight certain solid cancers by remotely adjusting their activity against tumor targets.

    NIH research Mabswitch, INC. · Van Nuys, United States · NIH-11313251

  • Using tumor-targeting viruses to boost CAR T cell treatment for solid tumors

    This work aims to help CAR T cell therapy work better for people with solid tumors by combining CAR T cells with cancer-killing viruses that ramp up the immune response.

    NIH research Mayo Clinic Rochester · Rochester, United States · NIH-11237992

  • Improving CAR T cell therapy for lung and other solid tumors

    This project works to make CAR T cell therapy more effective for people with lung and other solid tumors by building realistic tumor models and testing ways to overcome the tumors' immune defenses.

    NIH research Icahn School of Medicine at Mount Sinai · New York, United States · NIH-11169974

  • Improving CAR T cell therapy for children with solid tumors

    This study is testing a new way to make CAR T cell therapy work better for kids with solid tumors by using special T cells that target a protein called B7-H3, and it aims to see how safe and effective these modified cells are in helping children whose tumors haven't responded to other treatments.

    NIH research St. Jude Children's Research Hospital · Memphis, United States · NIH-11035233

  • Using oncolytic viruses to enhance CAR T cell therapy for solid tumors

    This study is looking at how using special viruses with CAR T cell therapy might help make the treatment work better for people with solid tumors by helping the CAR T cells find and attack the cancer more effectively.

    NIH research Mayo Clinic Rochester · Rochester, United States · NIH-10992143

  • Improving CAR T cell therapy for lung cancer

    This study is looking at ways to make CAR T cell therapy work better for lung cancer by creating a model that simulates the tumor environment, helping researchers figure out why it struggles with solid tumors and how to improve treatment for patients.

    NIH research Icahn School of Medicine at Mount Sinai · New York, United States · NIH-10914088

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.